fda glp-1 warning news november 2025 The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.abc27.com/national/compounded-glp-1 -drugs-creating-concern-among-doctors-and-fda/?utm_medium FDA takes aim at telehealth

How Does Fibre Support GLP-1

9-13, pmc.ncbi.nlm.nih.gov/articles/PMC4674353

The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)

Constipation Due to a lack of essential nutrients caused by restricted food intake, weight-loss drugs can lead to constipation, as the body doesnt receive the necessary nutrients to maintain proper digestive function

Whey protein has the highest bioavailability but can worsen GI symptoms in some people